Prostate cancer detection and early stage management

Written in association with: Mr Ammar Alanbuki
Published:
Edited by: Aoife Maguire

Prostate cancer is a significant concern for men, particularly as they age. Early detection is key to successful treatment. Leading consultant urologist Mr Ammar Alanbuki explains all you need to know about detection and diagnosis.

 

 

How is prostate cancer detected at its earliest stage?

 

Prostate cancer is often detected at its earliest stage through routine screening. The two primary methods for early detection are the prostate-specific antigen (PSA) blood test and the digital rectal exam (DRE). The PSA test measures the level of PSA in the blood, with elevated levels possibly indicating the presence of prostate cancer. The DRE involves a physical examination of the prostate through the rectum to detect abnormalities in size, shape, or texture.

 

Is cure and full recovery guaranteed if it is detected early?

 

While early detection greatly increases the chances of successful treatment, it does not guarantee a cure or full recovery. Many cases of early-stage prostate cancer can be treated effectively, often leading to long-term remission or even cure. However, outcomes can vary based on factors such as the cancer’s aggressiveness, the patient’s overall health, and how well the cancer responds to treatment.

 

What tests are carried out to detect prostate cancer at its earliest stage?

 

The primary tests for detecting prostate cancer at its earliest stage include the PSA test and the DRE. If either test suggests the possibility of cancer, further testing such as a prostate biopsy, MRI, or ultrasound may be recommended to confirm the diagnosis. Newer diagnostic techniques, such as MRI-targeted biopsy, can help pinpoint the exact location of cancer within the prostate, improving the accuracy of detection.

 

What happens after the diagnosis is made?

 

After a diagnosis of prostate cancer is made, the next steps typically involve determining the stage and grade of the cancer. This includes assessing how far the cancer has spread (staging) and how aggressive it is (grading). Based on this information, a treatment plan is developed, which may include options like active surveillance, surgery, radiation therapy, hormone therapy, or a combination of these.

 

The choice of treatment is tailored to the individual’s specific situation, with input from a multidisciplinary team of healthcare providers. Early detection and a clear understanding of treatment options can significantly influence outcomes, making regular screening important for at-risk men.

 

 

If you are concerned about prostate cancer and would like to book a consultation with Mr Alanbuki do not hesitate to do so by visiting his Top Doctors profile today

By Mr Ammar Alanbuki
Urology

Mr. Ammar Alanbuki: A Leading Consultant Urologist Committed to Excellence
 
With a distinguished career spanning over two decades, Mr. Ammar Alanbuki is a renowned consultant urologist offering exceptional care at Nuffield Health Brighton Hospital, Nuffield Health Haywards Heath, Spire Montefiore Hospital, Spire Gatwick park and the Onewelbeck Heath. His expertise encompasses a wide range of urological conditions, including prostate cancer, prostate enlargement, bladder and kidney cancer, Robotic surgery, kidney stones, penile and scrotal pathologies, and female urology.
 
A Strong Academic Foundation and Advanced Training
Mr. Alanbuki began his medical journey in 1998, graduating from Al-Mustansirya University in Iraq. He honed his skills during his basic surgical training in the northeast of England before advancing as a research fellow at Barts and The London University Hospitals, where he contributed to the REDUCE trial (Reduction by Dutasteride of Prostate Cancer Events). His commitment to mastering his field led him to join the Eastern Deanery’s higher surgical training program, where he gained extensive experience in diagnostic and therapeutic urology.
 
In his pursuit of excellence, Mr. Alanbuki undertook sub-specialist training at the Norfolk and Norwich University Hospitals, focusing on endourology, laparoscopic kidney surgery, and stone disease. His academic endeavors include a groundbreaking research project on the management of testicular tumors, which earned him a master’s degree from Teesside University.
 
A Respected Consultant and Researcher
Since 2016, Mr. Alanbuki has served as a consultant urological surgeon at Brighton and Sussex NHS Trust, where he combines cutting-edge techniques with compassionate patient care. His dedication to research and innovation ensures that his patients benefit from the latest advancements in urology.
 
Mr. Alanbuki has an impressive portfolio of peer-reviewed publications and is an active contributor to national and international medical conferences. His memberships in prestigious organizations such as the American Urological Association and the European Association of Urology reflect his commitment to staying at the forefront of his field.
 
Patient-Centered Care with a Global Perspective
With his wealth of experience, advanced skills, and a deep commitment to improving patient outcomes, Mr. Alanbuki is dedicated to providing the highest standard of care. Whether addressing complex cases or offering minimally invasive solutions, his practice is guided by a passion for innovation and excellence in urology.
 

View Profile

Overall assessment of their patients


  • Related procedures
  • Sexually transmitted infections (STIs)
    Vaginoplasty
    Penis Enlargement (Phalloplasty)
    Adult circumcision
    Laparoscopy
    Urologic Oncology
    Geriatric Urology
    Kidney transplantation
    Phimosis
    Short frenulum
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.